login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
STRUCTURE THERAPEUTICS INC (GPCR) Stock News
NASDAQ:GPCR -
US86366E1064
-
ADR
19.84
USD
+0.54 (+2.8%)
Last: 9/2/2025, 10:58:23 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GPCR Latest News, Press Relases and Analysis
All
Press Releases
3 hours ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
a month ago - By: Benzinga
- Mentions:
LLY
NVO
VKTX
TERN
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
7 months ago - By: The Motley Fool
Why Structure Therapeutics Stock Was Stumbling This Week
a month ago - By: Investor's Business Daily
- Mentions:
LLY
NVO
VKTX
Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.
a month ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
a month ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
2 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
2 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
3 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
4 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights
4 months ago - By: Yahoo Finance
- Mentions:
TXN
LIVN
EWTX
IGT
...
Jim Cramer Applauds Texas Instruments (TXN): “Put Up Terrific Numbers”
5 months ago - By: Benzinga
- Mentions:
EVO
DLTR
IIIN
CAR
...
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
5 months ago - By: Bloomberg
- Mentions:
PFE
VKTX
TERN
MTSR
Pfizer Setback Spurs Rise in Obesity Developers on M&A Hopes
5 months ago - By: The Motley Fool
- Mentions:
VKTX
PFE
NVO
LLY
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
6 months ago - By: Investor's Business Daily
- Mentions:
ABBV
LLY
NVO
VKTX
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
6 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
7 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
7 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
7 months ago - By: MarketBeat
- Mentions:
RXRX
SDGR
NVS
LLY
AI Pharma: 2 Paths to AI-Powered Drug Investment
8 months ago - By: Investor's Business Daily
- Mentions:
MRNA
ALNY
EXEL
CORT
...
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
9 months ago - By: Investor's Business Daily
- Mentions:
LLY
PFE
MRK
AZN
...
Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche
9 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
9 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
9 months ago - By: Investor's Business Daily
- Mentions:
LLY
NVO
PFE
AMGN
...
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
9 months ago - By: Investor's Business Daily
- Mentions:
LLY
NVO
AMGN
PFE
...
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
Please enable JavaScript to continue using this application.